Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909673 · ClinicalTrials.gov registry record · NA
School Based Program to Prevent Teen Dating Violence
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 3,028
- Enrollment target
NCT02909673: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT02909673 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3,028 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (116% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909673, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,028 participants
- Enrollment target
Study Summary
This study is a school-based trial of the 7th grade version of Fourth R, a promising teen dating violence prevention program, with 24 ethnically diverse middle schools in one of the nation's largest school districts to determine the impact of the program by comparing students in intervention schools with those in control schools.
Primary Outcome
Determine whether Fourth R reduces students' TDV, as indexed by less perpetration of physical TDV, relative to students in control schools.
Interventions
- BEHAVIORAL Fourth R
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,028 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2023-12-07 |
| Phase | NA |
What the finished NCT02909673 record still lists
NCT02909673 is an interventional study that assigns participants to a tested intervention. Its 3,028 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (116% higher).
The record links to 0 conditions, and to 1 intervention - of which Fourth R is the first listed.
NCT02909673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02909673 about?
NCT02909673 is a clinical study titled "School Based Program to Prevent Teen Dating Violence". This study is a school-based trial of the 7th grade version of Fourth R, a promising teen dating violence prevention program, with 24 ethnically diverse middle schools in one of the nation's largest school districts to determine the impact of the program by comparing students in intervention schools...
What is the current status of trial NCT02909673?
This trial is currently completed. It is a NA study. The enrollment target is 3,028 participants. The study started on 2018-01-18. Estimated completion is 2023-12-07.
What interventions are being tested in trial NCT02909673?
The interventions under investigation include: Fourth R (BEHAVIORAL).
Who is sponsoring clinical trial NCT02909673?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02909673's enrollment target sits among peer trials
3,028 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI